Muscle-specific alternative splicing of myotubularin-related 1 gene is impaired in DM1 muscle cells

Human Molecular Genetics

Volumn 11, Issue 19, 2002, Pages 2297-2307

  Buj Bello, Anna ^a   Furling, Denis ^b   Tronchère, Hélène ^c   Laporte, Jocelyn ^a   Lerouge, Thierry ^a   Butler Browne, Gillian S ^b   Mandel, Jean Louis ^a  

^a INSTITUT DE GÉNÉTIQUE ET DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c CHU PURPAN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ISOPROTEIN; MESSENGER RNA; MYOTUBULARIN; MYOTUBULARIN RELATED 1 PROTEIN; PHOSPHATASE; UNCLASSIFIED DRUG;

ALTERNATIVE RNA SPLICING; ANIMAL CELL; ARTICLE; CELL CULTURE; CENTRONUCLEAR MYOPATHY; CONTROLLED STUDY; DEVELOPMENT; DISEASE SEVERITY; EUKARYOTE; EXON; GENE EXPRESSION; GENE MUTATION; GENETIC CONSERVATION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INTRON; MOUSE; MULTIGENE FAMILY; MUSCLE CELL; MUSCLE DEVELOPMENT; MYOTONIC DYSTROPHY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; RNA SPLICING; SEQUENCE HOMOLOGY; SKELETAL MUSCLE; TISSUE DIFFERENTIATION; TISSUE SPECIFICITY; X CHROMOSOME; X CHROMOSOME LINKAGE;

ANIMALIA; EUKARYOTA;

EID: 0037106539     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/11.19.2297     Document Type: Article

References (37)

1. Laporte, J., Blondeau, F., Buj-Bello, A. and Mandel, J.L. (2001) The myotubularin family: from genetic disease to phosphoinositide metabolism. Trends Genet., 17, 221-228.
2. Wishart, M.J., Taylor, G.S., Slama, J.T. and Dixon, J.E. (2001) PTEN and myotubularin phosphoinositide phosphatases: bringing bioinformatics to the lab bench. Curr. Opin. Cell Biol., 13, 172-181.
3. Nandurkar, H.H., Caldwell, K.K., Whisstock, J.C., Layton, M.J., Gaudet, E.A., Norris, F.A., Majerus, P.W. and Mitchell, C.A. (2001) Characterization of an adapter subunit to a phosphatidylinositol (3)P 3-phosphatase: identification of a myotubularin-related protein lacking catalytic activity. Proc. Natl Acad. Sci. USA, 98, 9499-9504.
4. Wallgren-Pettersson, C., Clarke, A., Samson, F., Fardeau, M., Dubowitz, V., Moser, H., Grimm, T., Barohn, R.J. and Barth, P.G. (1995) The myotubular myopathies: differential diagnosis of the X linked recessive, autosomal dominant, and autosomal recessive forms and present state of DNA studies. J. Med. Genet., 32, 673-679.
5. Laporte, J., Hu, L.J., Kretz, C., Mandel, J.L., Kioschis, P., Coy, J.F., Klauck, S.M., Poustka, A. and Dahl, N. (1996) A gene mutated in X-linked myotubular myopathy defines a new putative tyrosine phosphatase family conserved in yeast. Nat. Genet., 13, 175-182.
6. Laporte, J., Biancalana, V., Tanner, S.M., Kress, W., Schneider, V., Wallgren-Pettersson, C., Herger, F., Buj-Bello, A., Blondeau, F., Liechti-Gallati, S. et al. (2000) MTM1 mutations in X-linked myotubular myopathy. Hum. Mutat., 15, 393-409.
7. Fardeau, M. (1992) Skeletal Muscle Pathology. Churchill Livinstone, Edinburgh.
8. Mandel, J.-L., Laporte, J., Buj-Bello, A., Sewry, C. and Wallgren-Pettersson, C. (2002) In Karpati, G. (ed.), Structural and Molecular Basis of Skeletal Muscle Diseases. ISN Neuropath Press, Basel, pp. 124-129.
9. Blondeau, F., Laporte, J., Bodin, S., Superti-Furga, G., Payrastre, B. and Mandel, J.L. (2000) Myotubularin, a phosphatase deficient in myotubular myopathy, acts on phosphatidylinositol 3-kinase and phosphatidylinositol 3-phosphate pathway. Hum. Mol. Genet., 9, 2223-2229.
10. Taylor, G.S., Maehama, T. and Dixon, J.E. (2000) Inaugural article: myotubularin, a protein tyrosine phosphatase mutated in myotubular myopathy, dephosphorylates the lipid second messenger, phosphatidylinositol 3-phosphate. Proc. Natl Acad. Sci. USA, 97, 8910-8915.
11. Gillooly, D.J., Morrow, I.C., Lindsay, M., Gould, R., Bryant, N.J., Gaullier, J.M., Parton, R.G. and Stenmark, H. (2000) Localization of phosphatidylinositol 3-phosphate in yeast and mammalian cells. Embo J., 19, 4577-4588.
12. Simonsen, A., Wurmser, A.E., Emr, S.D. and Stenmark, H. (2001) The role of phosphoinositides in membrane transport. Curr. Opin. Cell Biol., 13, 485-492.
13. Laporte, J., Blondeau, F., Buj-Bello, A., Tentler, D., Kretz, C., Dahl, N. and Mandel, J.L. (1998) Characterization of the myotubularin dual specificity phosphatase gene family from yeast to human. Hum. Mol. Genet., 7, 1703-1712.
14. Bolino, A., Muglia, M., Conforti, F.L., LeGuern, E., Salih, M.A., Georgiou, D.M., Christodoulou, K., Hausmanowa-Petrusewicz, I., Mandich, P., Schenone, A. et al. (2000) Charcot-Marie-Tooth type 4B is caused by mutations in the gene encoding myotubularin-related protein-2. Nat. Genet., 25, 17-19.
15. Kioschis, P., Wiemann, S., Heiss, N.S., Francis, F., Gotz, C., Poustka, A., Taudien, S., Platzer, M., Wiehe, T., Beckmann, G. et al. (1998) Genomic organization of a 225-kb region in Xq28 containing the gene for X-linked myotubular myopathy (MTM1) and a related gene (MTMR1). Genomics, 54, 256-266.
16. Harper, P.S. and Johnson, K. (2001) In (eds), Scriver, C.R., Beaudet, A.L., Sly, W.S. and Valle, D. The Metabolic and Molecular Bases of Inherited Disease. McGraw-Hill, New York, pp. 5525-5550.
17. Philips, A.V. and Cooper, T.A. (2000) RNA processing and human disease. Cell. Mol. Life Sci., 57, 235-249.
18. Kim, S.A., Taylor, G.S., Torgersen, K.M. and Dixon, J.E. (2002) Myotubularin and MTMR2, phosphatidylinositol 3-phosphatases mutated in myotubular myopathy and type 4B Charcot-Marie-Tooth disease. J. Biol. Chem., 277, 4526-4531.
19. Yu, Y.T., Breitbart, R.E., Smoot, L.B., Lee, Y., Mahdavi, V. and Nadal-Ginard, B. (1992) Human myocyte-specific enhancer factor 2 comprises a group of tissue-restricted MADS box transcription factors. Genes Dev., 6, 1783-1798.
20. Laporte, J., Liaubet, L., Blondeau, F., Tronchere, H., Mandel, J.L. and Payrastre, B. (2002) Functional redundancy in the myotubularin family. Biochem. Biophys. Res. Commun., 291, 305-312.
21. Laporte, J., Blondeau, F., Gansmuller, A., Lutz, Y., Vonesch, J.-L. and Mandel, J.-L. The PtdIns3P phosphatase myotubularin is a cytoplasmic protein that also localizes to Rac1-inducible plasma membrane ruffles. J. Cell Sci., 115, 3105-3117.
22. Philips, A.V., Timchenko, L.T. and Cooper, T.A. (1998) Disruption of splicing regulated by a CUG-binding protein in myotonic dystrophy. Science, 280, 737-741.
23. Savkur, R.S., Philips, A.V. and Cooper, T.A. (2001) Aberrant regulation of insulin receptor alternative splicing is associated with insulin resistance in myotonic dystrophy. Nat. Genet., 29, 40-47.
24. Sergeant, N., Sablonniere, B., Schraen-Maschke, S., Ghestem, A., Maurage, C.A., Wattez, A., Vermersch, P. and Delacourte, A. (2001) Dysregulation of human brain microtubule-associated tau mRNA maturation in myotonic dystrophy type 1. Hum. Mol. Genet., 10, 2143-2155.
25. Seznec, H., Agbulut, O., Sergeant, N., Savouret, C., Ghestem, A., Tabti, N., Willer, J.C., Ourth, L., Duros, C., Brisson, E. et al. (2001) Mice transgenic for the human myotonic dystrophy region with expanded CTG repeats display muscular and brain abnormalities. Hum. Mol. Genet., 10, 2717-2726.
26. Furling, D., Coiffier, L., Mouly, V., Barbet, J.P., St Guily, J.L., Taneja, K., Gourdon, G., Junien, C. and Butler-Browne, G.S. (2001) Defective satellite cells in congenital myotonic dystrophy. Hum. Mol. Genet., 10, 2079-2087.
27. Furling, D., Lemieux, D., Taneja, K. and Puymirat, J. (2001) Decreased levels of myotonic dystrophy protein kinase (DMPK) and delayed differentiation in human myotonic dystrophy myoblasts. Neuromuscul. Disord., 11, 728-735.
28. Copley, L.M., Zhao, W.D., Kopacz, K., Kioschis, P., Taudien, S., Platzer, M., Poustka, A. and Herman, G.E. (2000) Exclusion of MTMR1 as a frequent cause of X-linked myotubular myopathy. Am. J. Hum. Genet., 67, 412.
29. Doerks, T., Strauss, M., Brendel, M. and Bork, P. (2000) GRAM, a novel domain in glucosyltransferases, myotubularins and other putative membrane-associated proteins. Trends Biochem. Sci., 25, 483-485.
30. Fabre, S., Reynaud, C. and Jalinot, P. (2000) Identification of functional PDZ domain binding sites in several human proteins. Mol. Biol. Rep., 27, 217-224.
31. Taneja, K.L., McCurrach, M., Schalling, M., Housman, D. and Singer, R.H. (1995) Foci of trinucleotide repeat transcripts in nuclei of myotonic dystrophy cells and tissues. J. Cell Biol., 128, 995-1002.
32. Davis, B.M., McCurrach, M.E., Taneja, K.L., Singer, R.H. and Housman, D.E. (1997) Expansion of a CUG trinucleotide repeat in the 3′ untranslated region of myotonic dystrophy protein kinase transcripts results in nuclear retention of transcripts. Proc. Natl Acad. Sci. USA, 94, 7388-7393.
33. Thornton, C. (2002) In Karpati, G. (ed.), Structural and Molecular Basis of Skeletal Muscle Diseases. ISN Neuropath Press, Basel, pp. 108-114.
34. Charlet-B., N., Savkur, R.S., Singh, G., Philips, A.V., Grice, E.A. and Cooper, T.A. (2002) Loss of the chloride channel in DMI skeletal muscle due to misregulated alternative splicing. Mol. Cell, 10, 45-53.
35. Charlet-B., N., Logan, P., Singh, G. and Cooper, T.A. Dynamic antagonism between ETR-3 and PTB regulates cell type-specific alternative splicing. Mol. Cell, 9, 649-658.
36. Edom, F., Mouly, V., Barbet, J.P., Fiszman, M.Y. and Butler-Browne, G.S. (1994) Clones of human satellite cells can express in vitro both fast and slow myosin heavy chains. Dev. Biol., 164, 219-229.
37. Taylor, G.S. and Dixon, J.E. (2001) An assay for phosphoinositide phosphatases utilizing fluorescent substrates. Anal. Biochem., 295, 122-126.